Volitionrx Ltd SEC filings VNRX
Volitionrx Ltd has 1,004 filings in SEC EDGAR's recent list, going back to Aug 27, 2013. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 27, 2026 (material agreement, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Material agreement, Other events
|
Oct 27, 2026 | Oct 23, 2026 |
| 8-K |
Current report
Unregistered share sale
|
Sep 25, 2026 | Sep 22, 2026 |
| 8-K |
Current report
Unregistered share sale
|
Sep 15, 2026 | Sep 9, 2026 |
| 8-K |
Current report
Other events
|
Sep 14, 2026 | Sep 11, 2026 |
| EFFECT | Filing | Sep 9, 2026 | — |
| S-3/A | Form s-3/a | Sep 9, 2026 | — |
| S-3/A | Form s-3/a | Sep 8, 2026 | — |
| 8-K |
Current report
Material agreement
|
Sep 2, 2026 | Sep 2, 2026 |
| 8-K |
Current report
Unregistered share sale
|
Sep 2, 2026 | Aug 27, 2026 |
| S-3 | Shelf registration | Aug 28, 2026 | — |
| 8-K |
Current report
Unregistered share sale
|
Aug 24, 2026 | Aug 19, 2026 |
| S-8 | Employee stock plan registration | Aug 21, 2026 | — |
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2026 | Aug 13, 2026 |
| 8-K |
Current report
Unregistered share sale
|
Aug 7, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jul 21, 2026 | Jul 17, 2026 |
| EFFECT | Filing | Jul 17, 2026 | — |
| S-3 | Shelf registration | Jul 10, 2026 | — |
| 8-K |
Current report
Unregistered share sale
|
Jun 18, 2026 | Jun 17, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
Jun 10, 2026 | Jun 7, 2026 |
| 424B5 | Prospectus supplement | Jun 9, 2026 | — |
| 424B5 | Prospectus supplement | Jun 5, 2026 | — |
| DEF 14A | Proxy statement | Jun 2, 2026 | Jul 17, 2026 |
| 8-K |
Current report
Material agreement
|
May 22, 2026 | May 21, 2026 |
| 8-K |
Current report
Officer or director change
|
May 15, 2026 | May 12, 2026 |
| 10-Q | Quarterly report | May 14, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 14, 2026 | May 14, 2026 |
| PRE 14A | Preliminary proxy statement | May 13, 2026 | May 12, 2026 |
| 10-K/A | Amended annual report | Apr 30, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Apr 28, 2026 | Apr 28, 2026 |
| 8-K |
Current report
Listing notice, Other events
|
Apr 23, 2026 | Apr 23, 2026 |
| 8-K |
Current report
Other events
|
Apr 17, 2026 | Apr 17, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Apr 1, 2026 | Mar 31, 2026 |
| 10-K | Annual report | Mar 31, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 31, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Unregistered share sale
|
Feb 20, 2026 | Feb 17, 2026 |
| EFFECT | Filing | Feb 19, 2026 | — |
| CORRESP | Letter to the SEC | Feb 17, 2026 | — |
| UPLOAD | Letter from the SEC | Feb 13, 2026 | — |
| DEF 14A | Proxy statement | Feb 11, 2026 | Feb 10, 2026 |
| 8-K |
Current report
Listing notice, Other events
|
Feb 9, 2026 | Feb 6, 2026 |
| S-3 | Shelf registration | Feb 9, 2026 | — |
| D/A | Filing | Jan 28, 2026 | — |
| PRE 14A | Preliminary proxy statement | Jan 26, 2026 | Jan 22, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jan 8, 2026 | Jan 7, 2026 |
| 8-K |
Current report
Officer or director change
|
Dec 11, 2025 | Dec 5, 2025 |
| 10-Q | Quarterly report | Nov 13, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2025 | Nov 13, 2025 |
| 8-K/A |
Amended current report
Material agreement
|
Nov 13, 2025 | Nov 7, 2025 |
| 8-K/A |
Amended current report
Material agreement
|
Nov 10, 2025 | Nov 7, 2025 |
| 8-K |
Current report
Material agreement
|
Nov 7, 2025 | Nov 7, 2025 |
| 8-K |
Current report
Material agreement, Results of operations, Regulation FD disclosure
|
Oct 14, 2025 | Oct 10, 2025 |
| 424B5 | Prospectus supplement | Oct 14, 2025 | — |
| 424B5 | Prospectus supplement | Oct 9, 2025 | — |
| 10-Q/A | Amended quarterly report | Aug 15, 2025 | Jun 30, 2025 |
| 10-Q | Quarterly report | Aug 14, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2025 | Aug 14, 2025 |
| 424B5 | Prospectus supplement | Aug 14, 2025 | — |
| 8-K |
Current report
Material agreement, Other events
|
Aug 4, 2025 | Aug 1, 2025 |
| 424B5 | Prospectus supplement | Aug 4, 2025 | — |
| EFFECT | Filing | Jul 14, 2025 | — |
| CORRESP | Letter to the SEC | Jul 10, 2025 | — |
| UPLOAD | Letter from the SEC | Jul 10, 2025 | — |
| S-3 | Shelf registration | Jul 3, 2025 | — |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jun 20, 2025 | Jun 18, 2025 |
| D | Filing | May 30, 2025 | — |
| 10-Q | Quarterly report | May 15, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 15, 2025 | May 15, 2025 |
| DEF 14A | Proxy statement | Apr 29, 2025 | Apr 24, 2025 |
| RW WD | Filing | Apr 25, 2025 | — |
| 8-K |
Current report
Material agreement, Agreement ended
|
Apr 22, 2025 | Apr 22, 2025 |
| 424B5 | Prospectus supplement | Apr 22, 2025 | — |
| EFFECT | Filing | Apr 18, 2025 | — |
| CORRESP | Letter to the SEC | Apr 16, 2025 | — |
| RW | Filing | Apr 16, 2025 | — |
| EFFECT | Filing | Apr 15, 2025 | — |
| S-3/A | Form s-3/a | Apr 11, 2025 | — |
| CORRESP | Letter to the SEC | Apr 11, 2025 | — |
| UPLOAD | Letter from the SEC | Apr 10, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 4, 2025 | Apr 4, 2025 |
| S-1 | Registration statement | Apr 4, 2025 | — |
| PRE 14A | Preliminary proxy statement | Apr 4, 2025 | Jun 18, 2025 |
| 10-K | Annual report | Mar 31, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 31, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Mar 26, 2025 | Mar 24, 2025 |
| 424B5 | Prospectus supplement | Mar 26, 2025 | — |
| 8-K |
Current report
Material agreement, Other events
|
Dec 9, 2024 | Dec 5, 2024 |
| 424B5 | Prospectus supplement | Dec 9, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 15, 2024 | — |
| 10-Q | Quarterly report | Nov 14, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2024 | Nov 14, 2024 |
| S-3 | Shelf registration | Nov 8, 2024 | — |
| 8-K |
Current report
Officer or director change
|
Nov 6, 2024 | Nov 6, 2024 |
| 8-K |
Current report
Officer or director change
|
Sep 30, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Officer or director change
|
Sep 27, 2024 | Sep 26, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 16, 2024 | Sep 16, 2024 |
| 10-Q | Quarterly report | Aug 14, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2024 | Aug 14, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
Aug 12, 2024 | Aug 8, 2024 |
| 424B5 | Prospectus supplement | Aug 12, 2024 | — |
| S-8 | Employee stock plan registration | Jul 24, 2024 | — |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
|
Jul 3, 2024 | Jul 2, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 27, 2024 | Jun 27, 2024 |
| EFFECT | Filing | Jun 25, 2024 | — |
| 424B3 | Prospectus | Jun 25, 2024 | — |
| CORRESP | Letter to the SEC | Jun 21, 2024 | — |
| UPLOAD | Letter from the SEC | Jun 20, 2024 | — |
| S-3 | Shelf registration | Jun 14, 2024 | — |
| DEF 14A | Proxy statement | May 13, 2024 | Jul 2, 2024 |
| 10-Q | Quarterly report | May 13, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 13, 2024 | May 13, 2024 |
| PRE 14A | Preliminary proxy statement | Apr 26, 2024 | Jul 2, 2024 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change
|
Apr 26, 2024 | Apr 24, 2024 |
| D | Filing | Mar 26, 2024 | — |
| 10-K | Annual report | Mar 25, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 25, 2024 | Mar 25, 2024 |
| 8-K |
Current report
Other events
|
Mar 19, 2024 | Mar 19, 2024 |
| UPLOAD | Letter from the SEC | Jan 3, 2024 | — |
| 8-K |
Current report
Other events
|
Jan 2, 2024 | Dec 29, 2023 |
| CORRESP | Letter to the SEC | Dec 20, 2023 | — |
| UPLOAD | Letter from the SEC | Dec 15, 2023 | — |
| 8-K |
Current report
Other events
|
Dec 5, 2023 | Dec 5, 2023 |
| 10-Q | Quarterly report | Nov 14, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2023 | Nov 14, 2023 |
| 10-Q | Quarterly report | Aug 14, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2023 | Aug 14, 2023 |
| S-8 | Employee stock plan registration | Jul 14, 2023 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 30, 2023 | Jun 28, 2023 |
| 8-K |
Current report
Material agreement, Other events
|
Jun 5, 2023 | Jun 1, 2023 |
| 424B5 | Prospectus supplement | Jun 2, 2023 | — |
| 424B5 | Prospectus supplement | May 31, 2023 | — |
| 10-Q | Quarterly report | May 10, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 10, 2023 | May 10, 2023 |
| DEF 14A | Proxy statement | Apr 28, 2023 | Apr 28, 2023 |
| 10-K | Annual report | Mar 15, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 15, 2023 | Mar 15, 2023 |
| 8-K |
Current report
Material agreement, Results of operations, Other events
|
Feb 21, 2023 | Feb 17, 2023 |
| 424B5 | Prospectus supplement | Feb 21, 2023 | — |
| 424B5 | Prospectus supplement | Feb 16, 2023 | — |
| 8-K |
Current report
Officer or director change
|
Nov 25, 2022 | Nov 22, 2022 |
| 10-Q | Quarterly report | Nov 14, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2022 | Nov 14, 2022 |
| S-8 | Employee stock plan registration | Sep 30, 2022 | — |
| 8-K |
Current report
Officer or director change
|
Aug 16, 2022 | Aug 15, 2022 |
| 10-Q | Quarterly report | Aug 10, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2022 | Aug 10, 2022 |
| 8-K |
Current report
Material agreement, Results of operations, Other events
|
Aug 2, 2022 | Jul 29, 2022 |
| 424B5 | Prospectus supplement | Aug 1, 2022 | — |
| 424B5 | Prospectus supplement | Jul 28, 2022 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 14, 2022 | Jun 13, 2022 |
| 8-K |
Current report
Material agreement
|
May 20, 2022 | May 20, 2022 |
| 424B5 | Prospectus supplement | May 20, 2022 | — |
| 10-Q | Quarterly report | May 11, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations
|
May 11, 2022 | May 11, 2022 |
| DEF 14A | Proxy statement | Apr 28, 2022 | Apr 28, 2022 |
| 10-K | Annual report | Mar 30, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 30, 2022 | Mar 30, 2022 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Mar 29, 2022 | Mar 28, 2022 |
| 10-Q | Quarterly report | Nov 10, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2021 | Nov 10, 2021 |
| EFFECT | Filing | Nov 8, 2021 | — |
| CORRESP | Letter to the SEC | Nov 4, 2021 | — |
| S-3/A | Form s-3/a | Nov 4, 2021 | — |
| UPLOAD | Letter from the SEC | Sep 30, 2021 | — |
| S-3 | Shelf registration | Sep 24, 2021 | — |
| 10-Q | Quarterly report | Aug 11, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2021 | Aug 11, 2021 |
| S-8 | Employee stock plan registration | Jul 23, 2021 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 22, 2021 | Jun 17, 2021 |
| 10-Q | Quarterly report | May 11, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Results of operations
|
May 11, 2021 | May 11, 2021 |
| DEF 14A | Proxy statement | Apr 29, 2021 | Apr 29, 2021 |
| PRE 14A | Preliminary proxy statement | Apr 2, 2021 | Apr 2, 2021 |
| 8-K |
Current report
Officer or director change
|
Mar 29, 2021 | Mar 25, 2021 |
| 10-K | Annual report | Mar 22, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Results of operations
|
Mar 22, 2021 | Mar 22, 2021 |
| 8-K |
Current report
Material agreement, Other events
|
Feb 12, 2021 | Feb 10, 2021 |
| 424B5 | Prospectus supplement | Feb 11, 2021 | — |
| 424B5 | Prospectus supplement | Feb 9, 2021 | — |
| 8-K |
Current report
Results of operations, Other events
|
Feb 9, 2021 | Feb 9, 2021 |
| 8-K |
Current report
Officer or director change, Other events
|
Feb 2, 2021 | Feb 1, 2021 |
| 8-K |
Current report
Material agreement, Officer or director change
|
Jan 15, 2021 | Jan 15, 2021 |
| 8-K |
Current report
Officer or director change
|
Dec 3, 2020 | Dec 1, 2020 |
| 424B5 | Prospectus supplement | Nov 12, 2020 | — |
| 10-Q | Quarterly report | Nov 12, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2020 | Nov 12, 2020 |
| 10-Q | Quarterly report | Aug 13, 2020 | Jun 30, 2020 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2020 | Aug 13, 2020 |
| 8-K |
Current report
Shareholder vote results
|
Jun 22, 2020 | Jun 19, 2020 |
| DEFA14A | Additional proxy material | Jun 17, 2020 | — |
| 8-K |
Current report
Material agreement, Other events
|
May 22, 2020 | May 20, 2020 |
| 424B5 | Prospectus supplement | May 21, 2020 | — |
| 424B5 | Prospectus supplement | May 19, 2020 | — |
| 10-Q | Quarterly report | May 7, 2020 | Mar 31, 2020 |
| 8-K |
Current report
Results of operations
|
May 7, 2020 | May 7, 2020 |
| DEF 14A | Proxy statement | Apr 29, 2020 | Apr 29, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 23, 2020 | Apr 23, 2020 |
| PRE 14A | Preliminary proxy statement | Apr 1, 2020 | Apr 1, 2020 |
| 10-K | Annual report | Feb 20, 2020 | Dec 31, 2019 |
| 8-K |
Current report
Results of operations
|
Feb 20, 2020 | Feb 20, 2020 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- In Vitro & In Vivo Diagnostic Substances (SIC 2835)
- Listed as
- VNRX (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Henderson, NV
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 93314
- Former names
- VOLITIONRX LTD (until Oct 27, 2026); STANDARD CAPITAL CORP (until Sep 29, 2011)
Other In Vitro & In Vivo Diagnostic Substances companies
- Idexx Laboratories Inc /DE IDXX
- Lantheus Holdings, Inc. LNTH
- Neogen Corp NEOG
- Celldex Therapeutics, Inc. CLDX
- Intellia Therapeutics, Inc. NTLA
- QuidelOrtho Corp QDEL
- Achieve Life Sciences, Inc. ACHV
- Myriad Genetics Inc MYGN
Source: SEC EDGAR filings. This is company-reported data, not investment advice.